Description: Theradiag SA develops, manufactures, and markets in-vitro diagnostic products. It offers autoimmunity reagents; IMMUNO-TROL, a multi-parametric quality control tool; various instruments for autoimmunity and infectious diseases testing; SQA-V system, a semen analyzer; and V-Sperm for loading results, pictures, and videos of the samples into the computer. The company also provides instrumentation, including Theralis that integrates multiplex FIDIS immunofluorescence and ELISA; Theralis µ, a solution for medium sized laboratories; and FIDIS platform used in laboratory for analysis. In addition, it offers therapeutic drug monitoring services for treatment of chronic inflammatory diseases; and LISA tracker, a tool for monitoring of biotherapies, as well as Elisa and rapid tests for SARS-CoV 2 serology. The company was founded in 1986 and is based in Marne La Vallee, France.
Home Page: www.theradiag.com
14 rue Ambroise Croizat
Marne-la-Vallée,
77435
France
Phone:
33 1 64 62 10 12
Officers
| Name | Title |
|---|---|
| Mr. Bertrand De Castelnau | Chief Exec. Officer |
| Ms. Muriel Bardet | Chief Financial Officer |
| Mr. Ermis Parussini | Exec. Director of Operations and R&D |
| Mr. Roland Carbonnel | VP Marketing and Sales |
Exchange: PA
Country: FR : France
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.3483 |
| Price-to-Sales TTM: | 2.3249 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 60 |